DUBLIN, May 13, 2021 \/PRNewswire\/ -- The \"Recombinant DNA Technology - Global Market Trajectory & Analytics\" report has been added to ResearchAndMarkets.com's offering.<\/p>\n
Amid the COVID-19 crisis, the global market for Recombinant DNA Technology estimated at US$609.8 Million in the year 2020, is projected to reach a revised size of US$841.3 Million by 2027, growing at a CAGR of 4.7% over the period 2020-2027.<\/p>\n
Medical, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$631.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Medical segment is readjusted to a revised 3.4% CAGR for the next 7-year period.<\/p>\n
The U.S. Market is Estimated at $179.7 Million, While China is Forecast to Grow at 4.4% CAGR<\/p>\n
The Recombinant DNA Technology market in the U.S. is estimated at US$179.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$148.5 Million by the year 2027 trailing a CAGR of 4.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.<\/p>\n
Select Competitors (Total 32 Featured):<\/p>\n
Key Topics Covered: <\/p>\n
I. METHODOLOGY<\/p>\n
II. EXECUTIVE SUMMARY<\/p>\n
1. MARKET OVERVIEW<\/p>\n
2. FOCUS ON SELECT PLAYERS<\/p>\n
3. MARKET TRENDS & DRIVERS<\/p>\n
4. GLOBAL MARKET PERSPECTIVE<\/p>\n
III. MARKET ANALYSIS<\/p>\n
IV. COMPETITION<\/p>\n
For more information about this report visit https:\/\/www.researchandmarkets.com\/r\/epifxz<\/a><\/p>\n Media Contact:<\/p>\n Research and Markets Laura Wood, Senior Manager [emailprotected] <\/p>\n For E.S.T Office Hours Call +1-917-300-0470 For U.S.\/CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 <\/p>\n U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716<\/p>\n SOURCE Research and Markets<\/p>\n http:\/\/www.researchandmarkets.com<\/a><\/p>\n <\/p>\n Read more from the original source: DUBLIN, May 13, 2021 \/PRNewswire\/ -- The \"Recombinant DNA Technology - Global Market Trajectory & Analytics\" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Recombinant DNA Technology estimated at US$609.8 Million in the year 2020, is projected to reach a revised size of US$841.3 Million by 2027, growing at a CAGR of 4.7% over the period 2020-2027. Medical, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$631.4 Million by the end of the analysis period. Continue reading
\nInsights on the Recombinant DNA Technology Global Market to 2027 - Featuring Amgen, Bamboo Therapeutics and Biocon Among Others - PRNewswire<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"